Home BoAn Biotech Presents Updated Phase I Clinical Data of CLDN18.2-Targeting ADC BA1301 at 2026 ASCO Annual Meeting

BoAn Biotech Presents Updated Phase I Clinical Data of CLDN18.2-Targeting ADC BA1301 at 2026 ASCO Annual Meeting

May 30, 2026 23:58 CST Updated May 31, 02:04